I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 23% ± 7% | |
| glutamatergic neuron | 4 studies | 34% ± 12% | |
| GABAergic neuron | 3 studies | 30% ± 0% | |
| oligodendrocyte | 3 studies | 20% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 23% ± 7% | |
| glutamatergic neuron | 4 studies | 34% ± 12% | |
| GABAergic neuron | 3 studies | 30% ± 0% | |
| oligodendrocyte | 3 studies | 20% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 30% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2994.60 | 1445 / 1445 | 100% | 15.10 | 183 / 183 |
| breast | 100% | 1393.38 | 459 / 459 | 100% | 11.68 | 1117 / 1118 |
| ovary | 100% | 1692.46 | 180 / 180 | 100% | 11.28 | 429 / 430 |
| skin | 100% | 1194.19 | 1808 / 1809 | 100% | 12.27 | 471 / 472 |
| stomach | 100% | 1561.11 | 358 / 359 | 100% | 14.39 | 286 / 286 |
| intestine | 100% | 2766.66 | 966 / 966 | 100% | 13.96 | 525 / 527 |
| lung | 99% | 1228.94 | 575 / 578 | 100% | 13.75 | 1155 / 1155 |
| bladder | 100% | 2650.86 | 21 / 21 | 99% | 11.32 | 501 / 504 |
| prostate | 100% | 2023.89 | 245 / 245 | 99% | 7.95 | 499 / 502 |
| kidney | 100% | 916.97 | 89 / 89 | 99% | 8.54 | 893 / 901 |
| uterus | 100% | 2701.31 | 170 / 170 | 99% | 13.10 | 453 / 459 |
| thymus | 100% | 1285.02 | 652 / 653 | 99% | 9.00 | 597 / 605 |
| adrenal gland | 98% | 840.07 | 254 / 258 | 97% | 7.11 | 224 / 230 |
| liver | 99% | 611.58 | 224 / 226 | 95% | 6.34 | 387 / 406 |
| brain | 94% | 678.29 | 2483 / 2642 | 100% | 13.97 | 705 / 705 |
| pancreas | 92% | 483.50 | 303 / 328 | 99% | 10.39 | 176 / 178 |
| blood vessel | 100% | 2358.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.67 | 29 / 29 |
| spleen | 100% | 1157.06 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.68 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.19 | 1 / 1 |
| adipose | 100% | 1338.15 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 936.18 | 793 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 7.70 | 77 / 80 |
| heart | 95% | 1417.78 | 818 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 43% | 443.25 | 400 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005622 | Cellular component | intracellular anatomical structure |
| GO_0004386 | Molecular function | helicase activity |
| GO_0003724 | Molecular function | RNA helicase activity |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | DHX35 |
| Protein name | Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35) RNA helicase (EC 3.6.4.13) |
| Synonyms | C20orf15 DDX35 |
| Description | FUNCTION: May be involved in pre-mRNA splicing. |
| Accessions | ENST00000449559.1 Q5THR1 ENST00000373325.6 Q5THQ7 F2Z2Z2 ENST00000373323.8 [Q9H5Z1-2] ENST00000484417.5 ENST00000252011.8 [Q9H5Z1-1] ENST00000652169.1 Q9H5Z1 |
